IMI CANCER-ID: Validation of novel blood-based biomarker technologies in clinical settings

被引：0
|
作者：
Schange, Thomas [1 ]
Krahn, Thomas [1 ]
Pleier, Sabrina [1 ]
Pantel, Klaus [2 ]
Terstappen, Leon W. M. M. [3 ]
Baggiani, Barbara [4 ]
机构：
[1] Bayer Pharma AG, Wuppertal, Germany
[2] Univ Klin Eppendorf, Hamburg, Germany
[3] Univ Twente, Twente, Netherlands
[4] Menarini Silicon Biosyst, Bologna, Italy
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-1604
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1604
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Genome-Wide Identification and Validation of a Novel Methylation Biomarker, SDC2, for Blood-Based Detection of Colorectal Cancer
    Oh, TaeJeong
    Kim, Nayoung
    Moon, Youngho
    Kim, Myung Soon
    Hoehn, Benjamin D.
    Park, Chan Hee
    Kim, Tae Soo
    Kim, Nam Kyu
    Chung, Hyun Cheol
    An, Sungwhan
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (04): : 498 - 507
  • [22] Predicting Response to PRRT: Development and Validation of a Blood-Based Predictive Biomarker
    Bodei, L.
    Kidd, M.
    Van der Zwan, W.
    Singh, A.
    Severi, S.
    Drozdov, I
    Cwikla, J.
    Baum, R. P.
    Paganelli, G.
    Kwekkeboom, D.
    Krenning, E.
    Modlin, I
    NEUROENDOCRINOLOGY, 2018, 106 : 241 - 241
  • [23] A novel blood-based biomarker for detection of autism spectrum disorders
    Momeni, N.
    Bergquist, J.
    Brudin, L.
    Behnia, F.
    Sivberg, B.
    Joghataei, M. T.
    Persson, B. L.
    TRANSLATIONAL PSYCHIATRY, 2012, 2 : e91 - e91
  • [24] Blood-based biomarkers and novel technologies for the diagnosis of colorectal cancer and adenomas: a narrative review
    Magowan, Drew
    Abdulshafea, Mansour
    Thompson, Dominic
    Rajamoorthy, Shri-Ishvarya
    Owen, Rhiannon
    Harris, Dean
    Prosser, Susan
    BIOMARKERS IN MEDICINE, 2024, 18 (09) : 495 - 508
  • [25] A novel blood-based biomarker for detection of autism spectrum disorders
    N Momeni
    J Bergquist
    L Brudin
    F Behnia
    B Sivberg
    M T Joghataei
    B L Persson
    Translational Psychiatry, 2012, 2 : e91 - e91
  • [26] Clinical validation of a blood-based prognostic biomarker in Inflammatory bowel disease; towards personalised medicine in IBD
    Lyons, P.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S143 - S143
  • [27] Blood-Based Protein Biomarker Panel for the Detection of Colorectal Cancer
    Fung, Kim Y. C.
    Tabor, Bruce
    Buckley, Michael J.
    Priebe, Ilka K.
    Purins, Leanne
    Pompeia, Celine
    Brierley, Gemma V.
    Lockett, Trevor
    Gibbs, Peter
    Tie, Jeanne
    McMurrick, Paul
    Moore, James
    Ruszkiewicz, Andrew
    Nice, Edouard
    Adams, Timothy E.
    Burgess, Antony
    Cosgrove, Leah J.
    PLOS ONE, 2015, 10 (03):
  • [28] AN INTEGRATED APPROACH TO BLOOD-BASED CANCER DIAGNOSIS AND BIOMARKER DISCOVERY
    Min, Martin Renqiang
    Chowdhury, Salim
    Qi, Yanjun
    Stewart, Alex
    Ostroff, Rachel
    PACIFIC SYMPOSIUM ON BIOCOMPUTING 2014, 2014, : 87 - 98
  • [29] Independent blinded validation of a novel blood-based early pancreatic cancer detection test
    Strasser, Patrick Christian
    Bijlsma, Maarten F.
    Le Large, Tessa Y. S.
    Kazemier, Geert
    Thumfart, Norbert
    Schneider, Maximilian
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [30] Clinical Relevance of Plasma TGF-ß level as a potential blood-based Biomarker for Ovarian Cancer
    Reimann, S.
    Klotz, D.
    Link, T.
    Wilsch, K.
    Wimberger, P.
    Brunner, G.
    Kuhlmann, J. D.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2021, 81 (06) : E40 - E41
12345